Cardiology Activities
PCSK9 Inhibitors: Managing Hypercholesterolemia and Improving Patient Outcomes
0290-0000-19-109-H01-P
This program will analyze the most recent cost-effectiveness data for the use of PCSK9 inhibitors.
1.50
An American Journal of Managed Care® Symposium: Managing Treatment Gaps with PCSK9 Inhibitors
0290-0000-19-123-H01-P
This activity features a panel that includes a moderator, a physician, a pharmacist, and a managed care expert, all of whom offer unique perspectives on how PCSK9 inhibitors fit into the current treatment landscape of hypercholesterolemia.
1.50
The Pharmacist's Role in Improving Heart Failure Care Coordination
0290-0000-19-084-H01-P
This article will identify opportunities for pharmacists to intervene and improve transitions of care for patients with heart failure.
2.00
The Specialty Pharmacist's Role in Chronic Thromboembolic Pulmonary Hypertension Management
0290-0000-19-076-H01-P
This activity is designed to familiarize the audience with chronic thromboembolic pulmonary hypertension (CTEPH), a disease state with emerging pharmacotherapeutic options.
2.00